Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Marien

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Psychoneuroendocrinology|October 7, 2014
Noradrenergic influences in the basolateral amygdala on inhibitory avoidance memory are mediated by an action on α2-adrenoceptorsBarbara Ferry, Sandrine Parrot, Marc Marien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2005
The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cellsPamela Rizk, Julio Salazar, Rita Raisman-Vozari, et al.
Molecular Pharmacology|March 24, 2005
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stressSabine Traver, Bénédicte Salthun-Lassalle, Marc Marien, et al.
Molecular Pharmacology|October 23, 2002
Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neuronsJean-Denis Troadec, Marc Marien, Sophie Mourlevat, et al.
Synapse (New York, N.Y.)|October 14, 2003
Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and miceAnne-Sophie Villégier, Candice Drouin, Jean-Charles Bizot, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Extracellular hippocampal acetylcholine level controls amygdala function and promotes adaptive conditioned emotional responseLudovic Calandreau, Pierre Trifilieff, Nicole Mons, et al.
Experimental Neurology|May 5, 2005
Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidusThomas Debeir, Laure Ginestet, Chantal François, et al.
European Journal of Pharmacology|March 28, 2009
F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter releaseMarie-Bernadette Assié, Ouissame Mnie-Filali, Véronique Ravailhe, et al.
Journal of Neurochemistry|September 3, 2008
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecidDaniel Alvarez-Fischer, Serge Guerreiro, Stéphane Hunot, et al.
Antioxidants & Redox Signaling|June 15, 2006
Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonistSergey Kalinin, Paul E Polak, Jose L M Madrigal, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Psychoneuroendocrinology|October 7, 2014
Noradrenergic influences in the basolateral amygdala on inhibitory avoidance memory are mediated by an action on α2-adrenoceptorsBarbara Ferry, Sandrine Parrot, Marc Marien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2005
The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cellsPamela Rizk, Julio Salazar, Rita Raisman-Vozari, et al.
Molecular Pharmacology|March 24, 2005
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stressSabine Traver, Bénédicte Salthun-Lassalle, Marc Marien, et al.
Molecular Pharmacology|October 23, 2002
Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neuronsJean-Denis Troadec, Marc Marien, Sophie Mourlevat, et al.
Synapse (New York, N.Y.)|October 14, 2003
Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and miceAnne-Sophie Villégier, Candice Drouin, Jean-Charles Bizot, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 29, 2006
Extracellular hippocampal acetylcholine level controls amygdala function and promotes adaptive conditioned emotional responseLudovic Calandreau, Pierre Trifilieff, Nicole Mons, et al.
Experimental Neurology|May 5, 2005
Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidusThomas Debeir, Laure Ginestet, Chantal François, et al.
European Journal of Pharmacology|March 28, 2009
F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter releaseMarie-Bernadette Assié, Ouissame Mnie-Filali, Véronique Ravailhe, et al.
Journal of Neurochemistry|September 3, 2008
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecidDaniel Alvarez-Fischer, Serge Guerreiro, Stéphane Hunot, et al.
Antioxidants & Redox Signaling|June 15, 2006
Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonistSergey Kalinin, Paul E Polak, Jose L M Madrigal, et al.
Pageof 3